HHMI
BLUE

Howard Hughes Medical Institute’s bluebird bio BLUE Stock Holding History

Howard Hughes Medical Institute’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-59
Closed -$49K – 167
2015
Q4 		$49K Buy
+59
New +$58.9K 0.01% 149

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Howard Hughes Medical Institute's BLUE Position: Q1 2016 in Review

Howard Hughes Medical Institute sold out of bluebird bio (BLUE) in Q1 2016, closing a stake of 59 shares — an estimated $49K sold.

Howard Hughes Medical Institute first reported a position in BLUE in Q4 2015 and held it in 1 quarter. The position peaked at $49K in Q4 2015. 187 funds tracked by Wall St. Rank hold BLUE as of Q1 2016.

  • Howard Hughes Medical Institute reported no remaining bluebird bio position as of Q1 2016 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 59 bluebird bio shares in Q1 2016, an estimated $49K.
  • Howard Hughes Medical Institute first reported a position in bluebird bio in Q4 2015 and held it in 1 quarter.
  • Howard Hughes Medical Institute's bluebird bio position peaked at $49K in Q4 2015.
  • 187 funds tracked by Wall St. Rank held bluebird bio as of Q1 2016.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2016, filed 10 May 2016.